Under current budget rules, the PBS is unable to grow well into the next decade, so this makes new pricing policies an inevitable consequence of the government's commitment to list every medicine recommended by the PBAC. …
Latest Video
New Stories
-
The cost of immunoglobulin is on the rise
June 27, 2019 - - Latest News -
NZ's myeloma patients rely on hope - and everything else besides PHARMAC
June 27, 2019 - - Latest News -
Does PHARMAC serve patients or its ideological self?
June 27, 2019 - - Latest News -
NICE's Dillon: Change required to manage the coming 'revolution in medicines'
June 27, 2019 - - Latest News -
MA: More required to attract emerging therapies
June 26, 2019 - - Latest News -
Recognition for Sanofi's employee well-being program
June 26, 2019 - - Latest News -
NZ: Poor access and poor outcomes
June 26, 2019 - - Latest News